SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
+12.38%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$341M
AUM Growth
+$341M
(+0.05%)
Cap. Flow
-$30.9M
Cap. Flow
% of AUM
-9.04%
Top 10 Holdings %
Top 10 Hldgs %
53.88%
Holding
39
New
10
Increased
16
Reduced
6
Closed
7
Top Buys
| 1 |
Bausch Health
BHC
|
$21.5M |
| 2 |
AGN
Allergan plc
AGN
|
$18.4M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$12M |
| 4 |
Sanofi
SNY
|
$9.9M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$9.82M |
Top Sells
| 1 |
GSK
GSK
|
$30.7M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
$26.6M |
| 3 |
AbbVie
ABBV
|
$24.9M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$19.4M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$19M |
Sector Composition
| 1 | Healthcare | 85.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sanofi
SNY
$121B
| $32.2M | 9.43% |
705,112
+217,012
| +44% | +$9.9M |
|
2
Viatris
VTRS
$12.3B
| $26.1M | 7.65% |
463,300
-242,200
| -34% | -$13.7M |
|
3
Community Health Systems
CYH
$387M
| $23.5M | 6.88% |
435,100
+120,400
| +38% | +$6.49M |
|
|
4
Bausch Health
BHC
$2.74B
| $21.5M | 6.3% |
+150,300
| New | +$21.5M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $18.4M | 5.4% |
+71,600
| New | +$18.4M |
|
|
6
Teva Pharmaceuticals
TEVA
$21.1B
| $13.3M | 3.89% |
230,897
-337,499
| -59% | -$19.4M |
|
7
Biogen
BIIB
$19.4B
| $12.8M | 3.76% |
37,800
+11,000
| +41% | +$3.73M |
|
|
MGLN
8
DELISTED
Magellan Health Services, Inc.
MGLN
| $12.5M | 3.67% |
208,500
+200
| +0.1% | +$12K |
|
|
9
Ironwood Pharmaceuticals
IRWD
$214M
| $12M | 3.51% |
+781,800
| New | +$12M |
|
|
CNCE
10
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $11.5M | 3.38% |
866,200
+605,000
| +232% | +$8.06M |
|
11
CONMED
CNMD
$1.68B
| $11.2M | 3.28% |
248,900
-11,500
| -4% | -$517K |
|
|
COV
12
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $10.8M | 3.17% |
105,862
-185,638
| -64% | -$19M |
|
13
Insmed
INSM
$28.8B
| $10.5M | 3.07% |
677,600
+14,300
| +2% | +$221K |
|
|
SLXP
14
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $9.82M | 2.88% |
+85,400
| New | +$9.82M |
|
|
ICPT
15
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.66M | 2.83% |
+61,900
| New | +$9.66M |
|
|
XNPT
16
DELISTED
XENOPORT, INC.
XNPT
| $9.55M | 2.8% |
1,088,700
-246,600
| -18% | -$2.16M |
|
17
Orthofix Medical
OFIX
$592M
| $9.23M | 2.7% |
306,898
+5,300
| +2% | +$159K |
|
|
FPRX
18
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.98M | 2.63% |
332,474
+34,174
| +11% | +$923K |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $8.22M | 2.41% |
+212,503
| New | +$8.22M |
|
|
MDVN
20
DELISTED
MEDIVATION, INC.
MDVN
| $7.92M | 2.32% |
+79,500
| New | +$7.92M |
|
21
Travere Therapeutics
TVTX
$1.56B
| $7.78M | 2.28% |
635,700
+343,300
| +117% | +$4.2M |
|
|
RPRX
22
DELISTED
Repros Therapeutics Inc.
RPRX
| $7.62M | 2.23% |
764,406
+10,806
| +1% | +$108K |
|
|
MNTA
23
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $7.03M | 2.06% |
583,716
+129,116
| +28% | +$1.55M |
|
|
SGNT
24
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $6.74M | 1.97% |
268,300
+113,400
| +73% | +$2.85M |
|
|
CORI
25
DELISTED
Corium International, Inc.
CORI
| $6.18M | 1.81% |
1,012,420
+453,600
| +81% | +$2.77M |
|